Business/Finance

Moody's Upgrades Teva Rating to A3

January 15, 2010

HaloPure® disinfection cartridges to be used in WAL products

January 12, 2010

Compugen Raises Gross Proceeds of $20 Million Through Sale of Ordinary Shares

December 30, 2009

Novexel to be acquired by AstraZeneca

December 23, 2009

API Healthcare Acquires Clearview Staffing Software

December 22, 2009

California Stem Cell, Inc. Closes Series B Financing Round

December 21, 2009

Merck & Co, Inc to Acquire Avecia Biologics
December 17, 2009

Nexmed Closes Acquisition of Bio-Quant

December 14, 2009

Prescription Solutions' Generic Usage Rates Surpass All-Time Industry Highs, According to New Study

December 11, 2009

NanoPacific Holdings, Inc. Announces Exclusive License from the University of California at Los Angeles for Supramolecular Nanoparticles for Molecular Diagnostics and Therapeutics

December 9, 2009

Teva Announces the Submission of a Biologics License Application (BLA) For XM02 for the Treatment of Chemotherapy-Induced Neutropenia

December 1st, 2009

Xencor Licenses Antibody Optimization Technology

November 30, 2009

BK Medical Announces New Three-Year Agreement with MedAssets
November 24, 2009

Acurian Announces Licensing Agreement With i3 for Clinical Research Site Selection Services

November 19, 2009

iKaryos Diagnostics Initiates Commercial Operations for Personalized Genomic Cancer Testing

November 16, 2009

Pathway Genomics Partners with OptumHealthSM Allies

November 12, 2009

Dow AgroSciences, Chromatin Announce Research, License Agreements

November 11, 2009

Enzon Announces Agreement to Sell Specialty Pharmaceutical Business
November 9, 2009

Graceway Pharmaceuticals Acquires Worldwide Rights to GS 9191 from Gilead Sciences

November 6, 2009

Aureus Pharma extends its knowledge database agreement with sanofi-aventis R&D

November 5, 2009

Novartis announces USD 1 billion investment to build largest pharmaceutical R&D institute in China

November 3, 2009

LFB Provides $10 Million of Funding to GTC Biotherapeutics

November 2nd, 2009

Inhibitex Completes $23 Million Financing

October 29,2009

Medtronic Launches New Neuro Oncology Surgical Imaging System Internationally

October 27, 2009

Yissum Announces Long-Term Multi-Project Research and License Collaboration with Roche

October 25, 2009

IMS Forecasts Global Pharmaceutical Market Growth of 4 - 6% in 2010; Predicts 4 - 7% Expansion Through 2013

October 14, 2009

NanoBio and the University of Michigan to Receive $9.3M from the NIH for Nanoemulsion-Based Vaccine Development

October 13, 2009

Galapagos achieves first milestone in anti-infectives alliance with GlaxoSmithKline

October 7, 2009

Tetraphase Pharmaceuticals Completes Series B Financing to Support the Advancement of Novel Antibiotic Drug Candidates

October 6, 2009

Novelos Therapeutics Announces $ 1 Million NIH Grant to MGH to Study NOV-002 and NOV-205 in Animal Models of Radiation-Induced Lung Injury
September 29, 2009

SynCardia Announces Exclusive Licensing Agreement for AorTech Polymer Heart Valve

September 22, 2009

Antigenics Announces Expansion of its QS-21 License Agreement

September 21, 2009

Rexahn Pharmaceuticals and Teva Pharmaceutical Industries Agree to Close on a License Agreement

September 17, 2009

Nuveta, Inc. Secures Series a Financing For In Vitro Fertilization Technology

September 16, 2009

BioMarker Strategies Raises $1.7 Million, including Investment by Abell Foundation

September 11, 2009

Inviragen Receives Additional Grant to Support Dengue Vaccine Development

September 10, 2009

United BioSource Corporation Announces Acquisition of Cognitive Drug Research Ltd. to Advance Services in Cognitive Testing in Clinical Research

September 10, 2009

NIH Issues $2.87 Million Grant for Development of Ceragenin(TM)-Based Drug to Treat Clostridium difficile and Shigella Gastrointestinal Infections

September 9, 2009

Cell Biosciences Signs Agreement to Acquire Alpha Innotech

September 8, 2009

Intrexon Announces Purchase of Industry-Leading Bioassay Operation

September 1st, 2009

BioClinica Acquires Cardionow from Afga Healthcare

September 1st, 2009

PsychoGenics and AstraZeneca Enter Agreement to Identify New Treatments for Central Nervous System Disorders

August 30, 2009

Polymedix and University of Massachusetts Receive $100,000 Contract to Develop Novel Antibacterial Compounds against Drug-Resistant Bacterial Biofilms

August 27, 2009

Novelos Therapeutics Announces $ 9 Million Private Placement

August 26, 2009

Nutra Pharma Announces Licensing Agreement with XenaCare Holdings to Market and Distribute Cobroxin, a Treatment for Chronic Pain

August 26, 2009

Syngenta Foundation for Sustainable Agriculture launches Syngenta and CIMMYT wheat Ug99 stem rust resistance research partnership

August 26, 2009

US Spine Announces Full National Launch of Preference 2 Complex Spine System

August 25, 2009

Approved as add-on therapy, Xolair offers a new treatment approach to nearly 35,000 children in the EU with uncontrolled severe persistent allergic asthma

August 24, 2009

Prolias Launches Family of Cardiovascular Based ProSpectrum LigandsTM
August 18, 2009

D-Pharm raises NIS 85 Million in rights offering and Initial Public Offering (IPO) on the Tel Aviv Stock Exchange (TASE)
August 17, 2009

AstraZeneca and Forest Laboratories to Co-Develop and Commercialize a Late Stage Next Generation Anti-Infective

August 12, 2009

BioAdvance Funds Treventis to Advance Alzheimer's Drug Discovery

August 10, 2009

Acetylon Pharmaceuticals Raises $7.25 Million Series A to Develop Next-Generation Selective HDAC Inhibitors for Cancer and Rheumatoid Arthritis

August 7, 2009

Merck Shareholders Approve Merger with Schering-Plough

August 7, 2009

Celera and Aurora Enter Collaboration for Use of Cardiovascular Genetics
August 6, 2009

InNexus Announces Business Development Initiative for DXL625, Royalty Pharma Comments

August 5, 2009

LabCorp Successfully Completes Cash Tender Offer for Outstanding Shares of Monogram Biosciences, Inc.

August 4, 2009

FORMA Therapeutics Announces Collaboration to Discover Inhibitors of Protein-Protein Interactions for Oncology

July 29, 2009

Novasys Medical and AVEO Pharmaceuticals secure additional equity capital while Portola Pharmaceuticals enters into Worldwide License Agreement with Merck & Co., Inc.

July 27, 2009

Merck Reports Proposed Settlement of Litigation Involving Planned Merger with Schering-Plough

July 24, 2009

BioDelivery Sciences Receives $27 Million Milestone Payment from Meda AB

July 22, 2009

Global Genomics Thought Leadership Forum, Genomic Pioneers Gateway Calls for Partnerships

July 21, 2009

Enigma Diagnostics Announces Signing of Patent Licenses with Roche Molecular Systems, Inc.